Related Experiment Video
Updated: Feb 5, 2026

Orthotopic Left Lung Transplantation in Rats
Published on: July 3, 2025
Risk factors for infection after pediatric lung transplantation
Chinyere Onyearugbulem1,2,3, Lauren Williams1,2, Huirong Zhu1,4
1Texas Children's Hospital, Houston, Texas.
Insights
In pediatric lung transplant recipients, prolonged donor ischemic time is a key risk factor for early post-operative infection. Reducing this time may decrease transplant-related complications.
Area of Science:
- Pediatric transplantation
- Infectious diseases
- Critical care medicine
Background:
- Infection is the primary cause of mortality within the first year after pediatric lung transplantation.
- Early post-operative sepsis is often under-recognized and under-reported in pediatric lung transplant recipients (LTRs).
- Limited data exist on the specific risk factors contributing to early infections in this vulnerable population.
Purpose of the Study:
- To determine the incidence of infection and sepsis in the early post-operative period for pediatric LTRs.
- To identify significant risk factors associated with early post-operative infection in pediatric LTRs.
Main Methods:
- Retrospective review of medical records for pediatric LTRs from January 2009 to March 2016.
- Analysis of microbiology results from post-transplant days 0-7.
- Sepsis defined using the 2005 International Pediatric Consensus Conference criteria.
- Evaluation of risk factors including donor/recipient infection history, multi-drug resistant (MDR) infection history, nutritional status, and surgical times.
Main Results:
- Out of 98 pediatric LTRs, 22 (22%) experienced post-operative infections.
- Prolonged donor ischemic time (≥7 hours), cardiopulmonary bypass (CPB) time (≥340 minutes), history of MDR infection, and cystic fibrosis diagnosis were associated with infection.
- Multivariable regression analysis identified prolonged donor ischemic time as the only significant independent risk factor (OR 4.4, 95% CI: 1.34-14.48).
Conclusions:
- Prolonged donor ischemic time is a significant risk factor for early post-operative infection in pediatric lung transplant recipients.
- Further research is warranted to explore strategies for reducing donor ischemic time to mitigate post-transplant morbidity.
Abstract:
Although infection is the leading cause of death in the first year following pediatric lung transplantation, there are limited data on risk factors for early infection. Sepsis remains under-recognized and under-reported in the early post-operative period for lung transplant recipients (LTR). We evaluated the incidence of infection and sepsis, and identified risk factors for infection in the early post-operative period in pediatric LTRs. A retrospective review of medical records of LTRs at a large quaternary-care hospital from January 2009 to March 2016 was conducted. Microbiology results on days 0-7 after transplant were obtained. Sepsis was defined using the 2005 International Pediatric Consensus Conferencecriteria. Risk factors included history of recipient and donor infection, history of multi-drug resistant (MDR) infection, nutritional status, and surgical times. Among the 98 LTRs, there were 22 (22%) with post-operative infection. Prolonged donor ischemic time ≥7 hours, cardiopulmonary bypass(CPB) time ≥340 minutes, history of MDR infection and diagnosis of cystic fibrosis were significantly associated with infection. With multivariable regression analysis, only prolonged donor ischemic time remained significant (OR 4.4, 95% CI: 1.34-14.48). Further research is needed to determine whether processes to reduce donor ischemic time could result in decreased post-transplant morbidity.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Relative Risk
Lung Capacity
Transcription Factors
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution

